BioSpace News Archive

Business

RxSight, Inc. Reports First Quarter 2023 Financial Results

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, reported financial results for the three months ended March 31, 2023.

May 9, 2023
·
10 min read
Business

Allakos Provides Business Update and Reports First Quarter 2023 Financial Results

Allakos Inc., a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, provided a business update and reported financial results for the first quarter ended March 31, 2023.

May 9, 2023
·
8 min read
Business

aTyr Pharma Announces First Quarter 2023 Results and Provides Corporate Update

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, announced first quarter 2023 results and provided a corporate update.

May 9, 2023
·
10 min read
Biotech Bay

Terns Pharmaceuticals to Participate in the JMP Securities 2023 Life Sciences Conference

Terns Pharmaceuticals, Inc. announced that management will participate in a fireside chat at the JMP Securities 2023 Life Sciences Conference on Monday, May 15, 2023 at 2:00 p.m. ET.

May 9, 2023
·
1 min read
Business

Standard BioTools Reports First Quarter 2023 Financial Results

Standard BioTools Inc., driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – reported financial results for the first quarter ended March 31, 2023.

May 9, 2023
·
17 min read
Business

Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate Update

Olema Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2023, and provided a corporate update.

May 9, 2023
·
9 min read
Business

GeneDx Reports First Quarter 2023 Financial Results and Business Highlights

GeneDx Holdings Corp., a leader in delivering improved health outcomes through genomic and clinical insights, reported its financial results for the first quarter of 2023.

May 9, 2023
·
17 min read
Business

Iovance Biotherapeutics Reports First Quarter 2023 Financial Results and Corporate Updates

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T-cell-based cancer immunotherapies (tumor infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), today reported first quarter 2023 financial results and corporate updates.

May 9, 2023
·
14 min read
Business

ProSomnus Reports First Quarter 2023 Financial Results

ProSomnus, Inc., a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea, announced financial results for the first quarter ended March 31, 2023.

May 9, 2023
·
12 min read
Business

Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, announced that the Company’s product portfolio of FDA-approved brands delivered combined revenues of $9.2 million during the first quarter of 2023.

May 9, 2023
·
21 min read